共 7 条
[1]
A multicenter open-label,randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. Frank E,Liu J,Kinasewitz G,et al. Clinical Therapeutics . 2002
[2]
Experience with levofloxacin in critical pathway for the treat ment of community-acquired pneumonia. Marrie TJ. Journal of Chemotherapy . 2004
[3]
Efficacy and safety of levofloxacin in the context of other contemporary fluroquinolones:A review. Ball P. Current Therapeutic Research . 2003
[4]
A multicenter,randomized study comparing the safety of intravenous and/or oral levofloxacin versus ceftriaxone an d/or cefuroxi me axetil in the treat ment of adults with community-acquired pneumonia. File TM,Segreti J,Dunbar L,et al. Antimicrobial Agents and Chemotherapy . 1997
[5]
Levofloxacin:An updated reviewof its use in the treat ment of bacterial infections. Hurst M,Lamb HM,Scott LJ,et al. Drugs . 2002
[6]
Infectious Diseases Society of America.Update of practice guidelines for the management of community-acquired pneumonia in i mmunocompetent adults. Mandell LA,Bartlett JG,Dowell SF,et al. Clinical Infectious Diseases . 2003
[7]
Practice guidelines for the management of community-acquired pneumonia in adults.Infectious Diseases Society of America. Bartlett JG,Dowell SF,Mandell LA,et al. Clinical Infectious Diseases . 2000